![](/img/cover-not-exists.png)
920TiPAfatinib in patients with advanced or metastatic urothelial carcinoma (UC) with genetic alterations in ErbB receptors 1–3 who failed on platinum-based chemotherapy: The Phase II LUX-Bladder 1 trial
Font, A., Real, F.X., Puente, J., Vazquez Mazon, F.J., Sala, N., Virizuela, J.A., Rodriguez-Vida, A., Grande Pulido, E., Castellano, D., Climent, M.A., Gallardo, E., González del Alba, A., Fernandez,Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx371.074
Date:
September, 2017
File:
PDF, 81 KB
2017